This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Fee Income Growth Support Huntington (HBAN) Q1 Earnings?
by Zacks Equity Research
Huntington's (HBAN) Q1 earnings are likely to have benefited from improved fee income, partly negated by low rates and high expenses.
This is Why T. Rowe Price (TROW) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: Lockheed Martin, Celanese, Virtu Financial, Polaris and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: Lockheed Martin, Celanese, Virtu Financial, Polaris and T. Rowe Price
5 ROE Picks as Markets Hit Top Gear With Solid Earnings Start
by Supriyo Bose
Lockheed Martin (LMT), Celanese (CE), Virtu Financial (VIRT), Polaris (PII) and T. Rowe (TROW) are some of the top ROE stocks to buy as markets trade near record highs.
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, Microsoft and T. Rowe Price
Screening for Triple Threat Stocks: Value, Growth and Dividends
by Tracey Ryniec
Is it possible for investors to find cheap stocks that have double digit growth and that also pay a great dividend yield?
Will T. Rowe (TROW) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
T. Rowe Price (TROW) March AUM Sees 1.3% Sequential Growth
by Zacks Equity Research
Diverse business model and the roll-out of new funds are likely to stoke T. Rowe Price's (TROW) AUM growth.
ATCO or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATCO vs. TROW: Which Stock Is the Better Value Option?
T. Rowe Price (TROW) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, CDW Corp and T. Rowe Price Group
by Zacks Equity Research
Zacks.com featured highlights include: East West Bancorp, HCA Healthcare, CDW Corp and T. Rowe Price Group
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
CBTX Hikes Dividend by 30%: Is the Stock Worth Considering?
by Zacks Equity Research
In a bid to add shareholder value, CBTX announces a 30% increase in its quarterly cash dividend. Investors may consider adding the stock to their portfolio based on dividend income.
JHG or TROW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JHG vs. TROW: Which Stock Is the Better Value Option?
Why T. Rowe Price (TROW) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does T. Rowe Price (TROW) have what it takes? Let's find out.
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
by Zacks Equity Research
Zacks.com featured highlights include: HCA Healthcare, East West Bancorp, CDW Corp, T. Rowe Price Group and KLA Corp
5 GARP Stocks for a Winning Portfolio
by Shilpa Mete
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
T. Rowe Price (TROW) Reports 2.7% Growth in February AUM
by Zacks Equity Research
Diverse business model and rollout of new funds are likely to stoke AUM growth of T. Rowe Price (TROW).
Invesco (IVZ) February AUM Up on Favorable Markets & Inflows
by Zacks Equity Research
Invesco (IVZ) witnesses a 1.8% sequential rise in February 2021 AUM.
Franklin (BEN) February AUM Up on Favorable Market Returns
by Zacks Equity Research
Franklin's (LAZ) February AUM rises sequentially on market appreciation and net inflows.
Cohen & Steers' (CNS) February AUM Improves on Upbeat Market
by Zacks Equity Research
Steadily rising AUM balance is expected to continue supporting Cohen & Steers' (CNS) revenues.
JHG vs. TROW: Which Stock Is the Better Value Option?
by Zacks Equity Research
JHG vs. TROW: Which Stock Is the Better Value Option?
T. Rowe Price (TROW) Unveils Shanghai Unit, Boosts Presence in China
by Zacks Equity Research
T. Rowe Price's (TROW) opening of investment research office in Shanghai will fortify its global research platform and help capitalize on the world's second largest equity market of China.